StreetInsider.com Pre-Open Movers 04/13

April 13, 2007 9:18 AM EDT

StreetInsider.com Pre-Open Movers:

Shares of Dyax Corp. (Nasdaq: DYAX) 44% HIGHER; announced positive topline results from its Phase 3, placebo-controlled trial, EDEMA3, for its lead product candidate DX-88 (ecallantide), for hereditary angioedema (HAE). Statistically significant results were achieved for both the primary and secondary endpoints in the EDEMA3 trial.

Semitool, Inc. (Nasdaq: SMTL) 19.2% LOWER; sees Q2 revenue of $51 to $53 million versus the company's prior revenue forecast of between $55 million and $57 million. The consensus is $56.45 million. Net bookings for the quarter were $37.8 million versus $50.9 million in the second quarter last year. The company also updated its 2007 fiscal year revenue forecast to a range of $210 million to $230 million versus its prior forecast of between $260 million and $310 million. The consensus is $273 million.

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) 15% HIGHER; the company and LG Life Sciences, Ltd., presented data from an in vitro study showing that ANA380 (LB80380) retains potency against multiple mutant strains of hepatitis B virus (HBV) which are resistant to lamivudine, adefovir, entecavir or telbivudine

Sallie Mae (NYSE: SLM) 12.4% HIGHER; According to reports from The New York Times, Sallie Mae is in takeover talks with private equity firms in deal that could be worth more than $20 billion.

Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX) 12% HIGHER; Highlighted in BusinessWeek

Planar Systems (NASDAQ: PLNR) 8.7% LOWER; expects Q2 sales to be $53-$54 million and Non-GAAP net loss per share to be $0.07 to $0.09. Past guidance was for sales of $57-$61 million and Non-GAAP net income per diluted share of $0.04 to $0.07 and GAAP net loss per share of $0.06 to $0.09.

Merck's (NYSE: MRK) 6% HIGHER; anticipates its first-quarter earnings per share will be $0.84 (reported EPS will be $0.78), citing strong revenue performance across the Company's range of products. The consensus is $0.63. The Company also raised its anticipated 2007 full-year EPS range to $2.75 to $2.85. The consensus is $2.65. The company also said an FDA panel votes 20 to 1 against Merck's Arcoxia pain reliever.

Krispy Kreme Doughnuts, Inc. (NYSE: KKD) 5% LOWER; said revenues for the fourth quarter decreased 8.2% to $112.2 million compared to $122.2 million in the fourth quarter of last year. The net loss for the fourth quarter was $24.4 million, or $0.39 per diluted share, compared to a net loss of $37.7 million, or $0.61 per diluted share, in the comparable period last year. The net loss for the quarter includes a charge related to the settlement of litigation of approximately $16.0 million. The Company recorded a $2.1 million provision for doubtful accounts. The Company recorded a $1.3 million charge related to the proposed settlement of certain wage and hour complaints.

SAP AG (NYSE: SAP) 3.8% HIGHER; Positive comments from Merrill Lynch

Annaly Capital Management, Inc. (NYSE: NLY) 2.8% HIGHER; Positive comments from Jim Cramer

Sirius Satellite Radio Inc. (NASDAQ: SIRI) 2.3% HIGHER; XM Satellite Radio (Nasdaq: XMSR) received from the Department of Justice a request for additional information and documentary material relating to our merger with Sirius Satellite.

Apple, Inc. (NASDAQ: AAPL) 1.4% LOWER; Delaying Leopard operating system to focus on iPhone

Nu Skin Enterprises (NYSE: NUS) INDICATED HIGHER; expects stronger-than-anticipated first-quarter revenue of approximately $273 million. The company also expects earnings per share to be within its previously announced range. (Consensus is $264.9 million)

Cott Corp. (NYSE: COT) INDICATED HIGHER; According to reports from the Wall Street Journal, private-label drinks maker Cott Corp. (NYSE: COT) is talking with private-equity firms about joining its operations with Cadbury Schweppes PLC's (NYSE: CSG) beverage arm.

Related Categories

General News
Special Reports

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?